teva pharmaceuticals introduces the first generic glp-1 for weight loss Launches Drug Saxenda Consumer group presses U.S. to
Description
This is where a framework Kushner helped develop for a Lancet Commission becomes useful
doi: 10.2337/diab.26.5.480
Patients who experience rapid dose escalation may be more prone to fatigue and gastrointestinal symptoms
[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Ha S., Wong V.W., Zhang X., Yu J
A.RosenstockJ.KimT.BurnsC.SkareS.et al (2016)
[DOI] [PubMed] [Google Scholar] 67.Harrold J.A., Hughes G.M., OShiel K., Quinn E., Boyland E.J., Williams N.J., Halford J.C
